The Tuskegee Syphilis Experiment has left a painful legacy of medical mistrust in the Black American community. In the 1932-1972 study, researchers withheld treatment from Black men infected with syphilis to observe the disease progression—without informing them of their diagnosis or that treatment was readily available.
“The awful thing about the Tuskegee experiment is people were not injected with syphilis…They did they were not offered a treatment that was known to be effective,” Dr. Jehan El-Bayoumi, an internal medicine doctor, better known as Dr. Gigi, told BDO. This unethical experiment bred deep distrust of the medical system that persists today.
However, Dr. Gigi cautions against dismissing medicine entirely due to this past wrong. She advocates nuance in response to Tuskegee’s complex legacy: “We have to be careful is to not throw out the baby with the bathwater,” Dr. Gigi argues.
We must stay vigilant against future harms but also recognize real benefits clinical research offers people of color today. While warranted, distrust can also prevent vulnerable groups from accessing cutting-edge, personalized treatments that improve outcomes.
Modern safeguards also prevent ethical breaches like Tuskegee moving forward. Per Dr. Gigi, “Because of the Tuskegee experiment, any sort of [clinical] trials that are done have these safeguards, where you have to have informed consent, you have to be able to understand what you’re tiny, you can’t just say, well, here, just sign this…You really have to understand it, understand what’s going on.”
Oversight bodies carefully evaluate proposed trials, as Dr. Gigi describes: “There is an institutional review board comprised of physicians, nurses, clergy, patients, scientists. And so they will look at this and say, well, is this a valid clinical trial? What are the potential harms to the patients?” These rigorous ethical standards help prevent future exploitative trials.
To help overcome distrust from past research abuses like the Tuskegee experiment, Dr. Gigi enrolled in a trial herself as a Black physician. She aims to “walk the walk” and lead by example, demonstrating the current protections and benefits clinical trial participation can offer.
Dr. Gigi sees clinical trial participation as an important way for Black Americans to contribute towards advancing medical science to serve their communities better.
However, Dr. Gigi cautions appropriately, “That doesn’t mean that we’re not gonna be vigilant, that we’re not gonna call out practices that are, you know, not ethical.” Ongoing advocacy remains essential even with safety guards in place.
As Dr. Gigi argues, “We need the people the policy people, all of it, the community activists, the individuals, to really rally.” We must continue scrutinizing the system and fighting so people of color get optimal treatment.
For example, through Dr. Edwin Chapman’s substance abuse trial on Black Americans, “He found that with this particular condition, substance use disorder with this particular medication, the medication was used up much, much more quickly in African American men.”
Ongoing participation and activism ensure people of color equitably benefit from advancing medicine. With greater representation, trials can better record outcomes for Black subgroups and adapt care standards accordingly.
While Tuskegee casts a long shadow, through nuanced remembrance of its lessons, stringent ethical oversight, and persistent participation and vigilance, we can overcome its harmful legacy. We can rebuild trust while still bettering medicine for us.
But overcoming Tuskegee’s damage requires nuance Dr. Gigi compels us towards—neither forgetting past harms nor missing current benefits by fully disengaging. As she advises, “We have to be careful to not throw out the baby with the bathwater.” From Tuskegee’s ashes, we must shape a system that serves everyone.
By subscribing, you consent to receive emails from BlackDoctor.com. You may unsubscribe at any time. Privacy Policy & Terms of Service.
